Modulation of Glucose-Induced Insulin Secretion from a Rat Clonal β-Cell Line*
- 1 December 1990
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 127 (6), 2779-2788
- https://doi.org/10.1210/endo-127-6-2779
Abstract
The present studies demonstrate that the .beta.-cell line RINr1046-38 (RIN-38) retains the capability to secrete insulin to response to glucose. The maximal effect of glucose was a 5- to 9-fold stimulation of insulin secretion from RIN-38 cells. This glucose-induced insulin secretion was maximal at 0.6 mM and was modulated by other secretagogues. Potassium concentrations of 10 mM, adenylate cyclase activators (glucagon-like peptide-1 and forskolin), and a phosphodiesterase inhibitor (isobutylmethylxanthine) potentiated glucose-induced insulin secretion, but had little or no effect on insulin secretion in the absence of glucose. Potassium concentrations of 20 mM or more, glibenclamide, and carbachol (Cch) stimulated insulin secretion 8- to 12-fold in the absence of glucose, while only Cch potentiated the effect of glucose on insulin secretion. Amino acids (alanine, arginine, leucine, and ketoisocaproate) also stimulated insulin secretion. The .alpha.2-adrenergic agonist clonidine (1 .mu.M), low extracellular calcium (.ltoreq. 0.5 mM), and extended culture of RIN-38 cells at low glucose concentrations (0.33 mM) inhibited the stimulatory effect of glucose on insulin secretion. Insulin secretion was retained in RIN-38 cells for up to 98 passages. However, extended passage was associated with a decline in cellular insulin content (83% decline over 89 passages). In addition, high passage cells lost the ability to secrete insulin in response to glucose, but continued to respond to other secretagogues (K+, alanine, and carbachol). In fact, in the absence of glucose the effect of Cch on insulin secretion was well maintained in high passage cells (8- and 9.9-fold increase in insulin secretion, passages 9 and 70, respectively). Thus, low passage RIN-38 cells secrete insulin in response to glucose and other insulin secretagogues. High passage cells do not respond to glucose, but continue to respond to other secretagogues. Based on these results we propose that high and low passage RIN-38 cells provide a model for examining molecular mechanisms of glucose-induced insulin secretion. In addition, these findings emphasize that passage information is essential for interpretation of secretion studies with RIN cell lines.Keywords
This publication has 39 references indexed in Scilit:
- EXPRESSION OF BOTH ALPHA-1 AND ALPHA-2 ADRENOCEPTORS IN AN INSULIN-SECRETING CELL-LINE - PARALLEL STUDIES OF CYTOSOLIC FREE CA-2+ AND INSULIN RELEASE1985
- Insulin, Glucagon, and Somatostatin Secretion by Cultured Rat Islet Cell Tumor and Its ClonesExperimental Biology and Medicine, 1984
- Abnormal glucose metabolism accompanies failure of glucose to stimulate insulin release from a rat pancreatic cell line (RINm5F)Biochemical Journal, 1983
- Regulation of immunoreactive-insulin release from a rat cell line (RINm5F)Biochemical Journal, 1983
- Insulin synthesis in a clonal cell line of simian virus 40-transformed hamster pancreatic beta cells.Proceedings of the National Academy of Sciences, 1981
- Dependency of Acetylcholine-Induced Insulin Release on Ca++Uptake by Rat Pancreatic Islets*Endocrinology, 1980
- Insulin secretory dynamics during development of rat pancreasAmerican Journal of Physiology-Endocrinology and Metabolism, 1980
- Continuous, clonal, insulin- and somatostatin-secreting cell lines established from a transplantable rat islet cell tumor.Proceedings of the National Academy of Sciences, 1980
- A comparison of the effects of glucose and acetylcholine on insulin release and intermediary metabolism in rat pancreatic islets.Journal of Biological Chemistry, 1979
- Coated Charcoal Immunoassay of InsulinJournal of Clinical Endocrinology & Metabolism, 1965